Creation of infectious disease treatment platform by novel nucleic acid therapeutics with remarkably enhanced catalytic target RNA cleavage activities
- Funded by Japan Agency for Medical Research and Development (AMED)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Funder
Japan Agency for Medical Research and Development (AMED)Principal Investigator
Professor Takehiko WADAResearch Location
JapanLead Research Institution
Institute of Multidisciplinary Research for Advanced Materials Professor, Tohoku UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable